Insiders

SEC Form 4 activity, with receipts.

Named insiders, transaction values, Veridion Score context, and SEC filing links in one ledger. Missing price or quantity rows are dropped, never zero-filled.

SEC Form 4 ledger

ACTU insider activity

ACTU

Score
54 · NEUTRAL
Pressure
Net selling
Filings
5
Buys / sells
3 / 2
Net value
-$652K
Insiders
5
Named filers
SM
SCHMITT DANIEL M
Insider
Leadership
TS
THOMSON TODD S
Insider
Leadership
BL
Bios Clinical Opportunity Fund, LP
Insider
Leadership
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Net selling: -$652K across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-02-132026-02-13SCHMITT DANIEL MInsidersell$4.33121,874150,181$528KSEC Form 4
2026-01-072026-01-05THOMSON TODD SInsidersell$5.80280,000904,795$1.6MSEC Form 4
2025-06-302025-06-27Bios Clinical Opportunity Fund, LPInsiderbuy$7.0071,428196,428$500KSEC Form 4
2025-06-302025-06-27BIOS Fund II NT, LPInsiderbuy$7.0071,428196,428$500KSEC Form 4
2025-06-302025-06-27BIOS Fund III, LPInsiderbuy$7.0071,428196,428$500KSEC Form 4
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Density audit
PageDepth vs barTop gap
Sovereign TerminalstrongKeep provenance dense as new panes are added.
Edge SuitestrongReserve-only reads need continued mobile audit.
Stock / ScorestrongInsider ledger now carries named filers and receipts.
Disclosure HubparHub links the disclosure surfaces, but needs more cross-surface summaries.
InsidersparConvergence becomes stronger as 13F coverage broadens.
NewsparNeeds more issuer-level receipts and source grouping.
Capital WebstrongAdd wider anchor coverage after current filer roster stabilizes.
Sector RankingsparRanking logic is useful, but drill-down context is still light.
WatchlistparNeeds more daily change explanations per ticker.
PortfolioparPer-holding Score table exists, but price/P&L attribution can be deeper.
ScreenerthinDefault result density depends on cold score dataset latency.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.